Literature DB >> 9695992

The human gallbladder increases cholesterol solubility in bile by differential lipid absorption: a study using a new in vitro model of isolated intra-arterially perfused gallbladder.

S Ginanni Corradini1, C Ripani, P Della Guardia, L Giovannelli, W Elisei, A Cantafora, M Codacci Pisanelli, G D Tebala, G Nuzzo, A Corsi, A F Attili, L Capocaccia, V Ziparo.   

Abstract

In this study, we first developed and validated a new in vitro isolated, intra-arterially perfused, gallbladder model and then applied the method to investigate the absorption of biliary lipids by the gallbladder wall and the effect of this process on the composition of human bile. Oxygenated and glucose-added buffer was perfused through the cystic artery to maintain organ viability. A standard pooled natural bile, radiolabeled with H3-cholesterol and C14-palmitoyl-linoleoyl-phosphatidylcholine, was instilled in the lumen via a cystic duct catheter. Changes in bile volume and lipid concentrations were monitored at time intervals to evaluate the disappearance of lipids from bile caused by gallbladder absorptive function. Organ viability was demonstrated by stable lactate dehydrogenase (LDH) organ release and oxygen consumption throughout the experiments. In the pig, disappearance rates of lipids from bile were similar in vitro and in vivo, demonstrating the validity of the isolated in vitro model for functional studies. By applying our in vitro isolated preparation to the human gallbladder, we found that 23% of cholesterol and 32% of phosphatidylcholine, but only 9% of bile salts, disappeared from bile in 5 hours. As a consequence, at the end of the experiments, cholesterol (P < .05) and phospholipid (P < .05) molar percentages were significantly reduced, while the bile salt (P < .05) molar percentage was significantly increased with respect to values at the beginning of the studies. Our findings are of pathophysiological relevance and support the concept that the human gallbladder modifies the relative composition of biliary lipids in such a way as to increase cholesterol solubility in bile.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695992     DOI: 10.1002/hep.510280205

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Biliary lipid composition in cholesterol microlithiasis.

Authors:  M Fracchia; S Pellegrino; P Secreto; L Gallo; G Masoero; A Pera; G Galatola
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

3.  MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.

Authors:  Laetitia Finzi; Véronique Barbu; Pierre-Regis Burgel; Martine Mergey; Kimberly S Kirkwood; Elizabeth C Wick; Jean-Yves Scoazec; Frédérique Peschaud; François Paye; Jay A Nadel; Chantal Housset
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 4.  Cholesterol gallstone disease: focusing on the role of gallbladder.

Authors:  Yongsheng Chen; Jing Kong; Shuodong Wu
Journal:  Lab Invest       Date:  2014-12-15       Impact factor: 5.662

5.  Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway.

Authors:  Jin Lee; Andrew Shirk; John F Oram; Sum P Lee; Rahul Kuver
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.

Authors:  Helen H Wang; Piero Portincasa; Min Liu; Patrick Tso; Linda C Samuelson; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-10-22

7.  Steatocholecystitis: the influence of obesity and dietary carbohydrates.

Authors:  Abhishek Mathur; Hayder H Al-Azzawi; Debao Lu; Kyle W Yancey; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Surg Res       Date:  2007-10-22       Impact factor: 2.192

8.  Relationship between gallbladder distension and lipid profiles in kawasaki disease.

Authors:  Ki-Won Kim; Hak Yong Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Woocheol Kwon; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

Review 9.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

10.  Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.

Authors:  Kevin M Tharp; Amin Khalifeh-Soltani; Hyo Min Park; David A Yurek; Alaric Falcon; Louis Wong; Rouying Feng; Kamran Atabai; Andreas Stahl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.